A novel TRB@/NOTCH1 fusion gene in T-cell lymphoblastic lymphoma with t(7;9)(q34;q34)

European Journal of Haematology

Volumn 90, Issue 1, 2013, Pages 68-75

  Yamamoto, Katsuya ^a   Nakamachi, Yuji ^b   Yakushijin, Kimikazu ^a   Miyata, Yoshiharu ^a   Okamura, Atsuo ^a   Kawano, Seiji ^b   Matsuoka, Hiroshi ^a   Minami, Hironobu ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY HOSPITAL   (Japan)

Author keywords

Fusion gene; NOTCH1; Polymerase chain reaction; T(7; 9)(q34; q34); T cell lymphoblastic lymphoma; TRB@

Indexed keywords

BUSULFAN; C REACTIVE PROTEIN; CD2 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAUNORUBICIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NELARABINE; NOTCH1 RECEPTOR; PREDNISONE; SOLUBLE INTERLEUKIN 2 RECEPTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN; VINCRISTINE;

5' UNTRANSLATED REGION; ADULT; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CHROMOSOME ANALYSIS; CHROMOSOME G BAND; CONSOLIDATION CHEMOTHERAPY; EXON; FUSION GENE; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOHISTOCHEMISTRY; KARYOTYPE 46,XY; KARYOTYPING; LYMPHADENOPATHY; LYMPHOMA CELL; MALE; MEDIASTINUM MASS; MULTIPLE CYCLE TREATMENT; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LYMPHOMA;

ADULT; BASE SEQUENCE; CHROMOSOME BANDING; CHROMOSOME BREAKPOINTS; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, PAIR 9; GENE ORDER; HUMANS; MALE; MOLECULAR SEQUENCE DATA; ONCOGENE FUSION; ONCOGENE PROTEINS, FUSION; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECEPTOR, NOTCH1; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SEQUENCE ALIGNMENT; TRANSLOCATION, GENETIC;

EID: 84871186564     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12019     Document Type: Article

References (21)

1. Grabher C, von Boehmer H, Look AT. Notch1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev 2006;6:347-59.
2. Paganin M, Ferrando A. Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia. Blood Rev 2011;25:83-90.
3. Aster JC, Blacklow SC, Pear WS. Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies. J Pathol 2011;223:262-73.
4. Smith SD, Morgan R, Gemmell R, Amylon MD, Link MP, Linker C, Hecht BK, Warnke R, Glader BE, Hecht F. Clinical and biologic characterization of T-cell neoplasias with rearrangements of chromosome 7 band q34. Blood 1988;71:395-402.
5. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD, Sklar J. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991;66:649-61.
6. Palomero T, Barnes KC, Real PJ, Glade Bender JL, Sulis ML, Murty VV, Colovai AI, Balbin M, Ferrando AA. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to γ-secretase inhibitors. Leukemia 2006;20:1279-87.
7. Speleman F, Cauwelier B, Dastugue N, et al. A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias. Leukemia 2005;19:358-66.
8. Mitelman F, Johansson B, Mertens F, eds. Mitelman database of chromosome aberrations and gene fusions in cancer. 2012. Updated on May 21, 2012. Available from: http://cgap.nci.nih.gov/Chromosomes/Mitelman. (accessed on 15th June, 2012).
9. Pear WS, Aster JC, Scott ML, Hasserjian RP, Soffer B, Sklar J, Baltimore D. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med 1996;183:2283-91.
10. Weng AP, Ferrando AA, Lee W, Morris JP IV, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT, Aster JC. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004;306:269-71.
11. Borowitz MJ, Chan JKC. T lymphoblastic leukaemia/lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, eds. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues, 4th edn. Lyon: International Agency for Research on Cancer; 2008:176-8.
12. Jinnai I, Sakura T, Tsuzuki M, et al. Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study. Int J Hematol 2010;92:490-502.
13. Schaffer LG, Slovak ML, Campbell LJ, eds. ISCN 2009: An International System for Human Cytogenetic Nomenclature. Basel: Karger, 2009.
14. Suzuki S, Nagel S, Schneider B, Chen S, Kaufmann M, Uozumi K, Arima N, Drexler HG, MacLeod RAF. A second NOTCH1 chromosome rearrangement: t(9;14)(q34.3;q11.2) in T-cell neoplasia. Leukemia 2009;23:1003-6.
15. Ashworth TD, Pear WS, Chiang MY, Blacklow SC, Mastio J, Xu L, Kelliher M, Kastner P, Chan S, Aster JC. Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1. Blood 2010;116:5455-64.
16. Jeannet R, Mastio J, Macias-Garcia A, et al. Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL. Blood 2010;116:5443-54.
17. Haydu JE, Keersmaecker KD, Duff MK, Paietta E, Racevskis J, Wiernik PH, Rowe JM, Ferrando A. An activating intragenic deletion in NOTCH1 in human T-ALL. Blood 2012;119:5211-4.
18. Galante PA, Sakabe NJ, Kirschbaum-Slager N, De Souza SJ. Detection and evaluation of intron retention events in the human transcriptome. RNA 2004;10:757-65.
19. Onozawa M, Aplan PD. Illegitimate V(D)J recombination involving nonantigen receptor loci in lymphoid malignancy. Genes Chromosom Cancer 2012;51:525-35.
20. Roth DB, Chang XB, Wilson JH. Comparison of filler DNA at immune, nonimmune, and oncogenic rearrangements suggests multiple mechanisms of formation. Mol Cell Biol 1989;9:3049-57.
21. Samon JB, Castillo-Martin M, Hadler M, et al. Preclinical analysis of the γ-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia. Mol Cancer Ther 2012;11:1565-75.